WEST is excited to host a networking night with leaders from Bristol-Myers Squibb on October 11th at the Broad Institute in Kendall Square. BMS will open their new R&D site in Cambridge this November where they plan to grow their team in key areas such as Oncology and Translational Medicine and Discovery Technologies. This location will be a flagship R&D site for the company with up to approximately 300 employees. Through their Bristol-Myers Squibb Network of Women (B-NOW) which advises on the hiring, compensation, and advancement of women in BMS to their 50.3% female workforce, BMS has demonstrated a strong commitment to an inclusive and diverse workforce.
Sandra Glucksmann, CEO of Cedilla Therapeutics and a founding board member of WEST, sat down with us to share her experience and lessons learned over her 25-year career in biotech. Sandra holds a PhD in molecular genetics and cell biology from the University of Chicago and carried out her post-doctorate work at MIT.
Sandra’s career path spanned both science and business. She attributes her success to being open to new opportunities that were not necessarily in her wheel house and to cultivating a strong network. After working as a bench scientist for eleven years at Millennium, she made a mid-career shift into the business side of biotech. She believes that staying deeply connected with her science background gave her a leg-up when developing her corporate presence in biotech.
Topics: Leadership, Women, Science, Career, Community, Giving Back, Success, Network, Inspire, Leader, Women in STEM, Presence, Biotech, Business, Change, Connect, Developing Your Skills, Strengths, Career Development, Influence Without Authority, PhD, New Opportunities, Mentor, Sponsor, Advice, Risk, Ask, Learn